Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Menopausal disorders and other disorders in the perimenopausal period”

View through CrossRef
This protocol was developed on the basis of the clinical guideline “Menopausal disorders and other disorders in the perimenopausal period”, which is based on the principles of evidence-based medicine and takes into account the clinical guideline Recommendations on Women’s Midlife Health and Menopause Hormone Therapy, developed in 2016 by specialists of the International Menopause Society (IMS), and corresponds to the specifics of providing medical care in our country.Also, other international guidelines on menopause issues were used in the development of this protocol, such as: “Menopause: diagnosis and management” National Institute for Health and Care Excellence (NICE) guideline, 2019; сlinical guidance “Managing menopausal symptoms” Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2020; “The genitourinary syndrome of menopause” North American Menopause Society, (NAMS), 2020; British Menopause Society (BMS) & Women’s Health Concern (WHC) recommendations on hormone replacement therapy in menopausal women, 2020.The goal of the protocol: to ensure the organization of medical care, to establish uniform requirements for the diagnosis and treatment of patients with menopausal symptoms, to recommend the use of STRAW+10 (2011) criteria for menopause to all health care professionals.The protocol describes the organization of medical care for patients with menopausal disorders at all levels – from primary to tertiary care. Detailed information on diagnosis and treatment of this category of patients is presented. Special attention is paid to menopausal hormone therapy, taking into account its possible risks.The protocol is intended for general practitioners – family doctors, obstetrician-gynecologists, gynecological oncologists, oncologists, oncological surgeons, cardiologists, endocrinologists, orthopedic traumatologists and other medical professionals who provide medical assistance to women with menopausal disorders.
Publishing Office TRILIST
Title: Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Menopausal disorders and other disorders in the perimenopausal period”
Description:
This protocol was developed on the basis of the clinical guideline “Menopausal disorders and other disorders in the perimenopausal period”, which is based on the principles of evidence-based medicine and takes into account the clinical guideline Recommendations on Women’s Midlife Health and Menopause Hormone Therapy, developed in 2016 by specialists of the International Menopause Society (IMS), and corresponds to the specifics of providing medical care in our country.
Also, other international guidelines on menopause issues were used in the development of this protocol, such as: “Menopause: diagnosis and management” National Institute for Health and Care Excellence (NICE) guideline, 2019; сlinical guidance “Managing menopausal symptoms” Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2020; “The genitourinary syndrome of menopause” North American Menopause Society, (NAMS), 2020; British Menopause Society (BMS) & Women’s Health Concern (WHC) recommendations on hormone replacement therapy in menopausal women, 2020.
The goal of the protocol: to ensure the organization of medical care, to establish uniform requirements for the diagnosis and treatment of patients with menopausal symptoms, to recommend the use of STRAW+10 (2011) criteria for menopause to all health care professionals.
The protocol describes the organization of medical care for patients with menopausal disorders at all levels – from primary to tertiary care.
Detailed information on diagnosis and treatment of this category of patients is presented.
Special attention is paid to menopausal hormone therapy, taking into account its possible risks.
The protocol is intended for general practitioners – family doctors, obstetrician-gynecologists, gynecological oncologists, oncologists, oncological surgeons, cardiologists, endocrinologists, orthopedic traumatologists and other medical professionals who provide medical assistance to women with menopausal disorders.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Osteoporosis in Surgical Menopause
Osteoporosis in Surgical Menopause
Background: Osteoporosis in both surgical and natural menopausal women are common health hazards all over the world. And the surgical menopausal women may have the greater chance o...
The severity of menopause and associated factors among middle aged women residing in Arba Minch, DHSS, Ethiopia, 2022
The severity of menopause and associated factors among middle aged women residing in Arba Minch, DHSS, Ethiopia, 2022
Abstract Background Menopausal symptoms are physiological symptoms that can be caused by a decrease in sex hormone levels particularly estrogen in the blood. It is among t...
Determinants of Breast Nodules in Perimenopausal Women: A Prospective Cohort Study
Determinants of Breast Nodules in Perimenopausal Women: A Prospective Cohort Study
Background: Perimenopausal women often require hormone replacement therapy (HRT), which is associated with an increased risk of developing breast nodules compared to women in other...
Assessment on severity of menopausal symptom and effectiveness of interventional package on quality of life among perimenopausal women
Assessment on severity of menopausal symptom and effectiveness of interventional package on quality of life among perimenopausal women
Introduction: Globally, the World Health Organization estimates that by 2030, millions of women will be either premenopausal or postmenopausal, highlighting the need for early iden...
Risk factors associated with postmenopausal bleeding and endometrial carcinoma.
Risk factors associated with postmenopausal bleeding and endometrial carcinoma.
Objective: The objectives of the study were to identify the common causes of post menopausal bleeding, benign and malignant causes of post menopausal bleeding and also the identifi...

Back to Top